AP1485A - Orally administered controlled delivery system for once daily administration of ciprofloxacin. - Google Patents

Orally administered controlled delivery system for once daily administration of ciprofloxacin.

Info

Publication number
AP1485A
AP1485A APAP/P/2002/002627A AP2002002627A AP1485A AP 1485 A AP1485 A AP 1485A AP 2002002627 A AP2002002627 A AP 2002002627A AP 1485 A AP1485 A AP 1485A
Authority
AP
ARIPO
Prior art keywords
ciprofloxacin
once daily
delivery system
orally administered
daily administration
Prior art date
Application number
APAP/P/2002/002627A
Other languages
English (en)
Other versions
AP2002002627A0 (en
Inventor
Naresh Talwar
John N Staniforth
Ashok Rampal
Gour Mukherji
Narayanan Badri N Vishwanathan
Brij Khera
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AP2002002627A0 publication Critical patent/AP2002002627A0/xx
Application granted granted Critical
Publication of AP1485A publication Critical patent/AP1485A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/2002/002627A 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin. AP1485A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (2)

Publication Number Publication Date
AP2002002627A0 AP2002002627A0 (en) 2002-09-30
AP1485A true AP1485A (en) 2005-10-31

Family

ID=24061635

Family Applications (2)

Application Number Title Priority Date Filing Date
APAP/P/2002/002627A AP1485A (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin.
APAP/P/2001/002084A AP2001002084A0 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily adminstration of ciprofloxacin

Family Applications After (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002084A AP2001002084A0 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily adminstration of ciprofloxacin

Country Status (31)

Country Link
EP (1) EP1263409A1 (et)
JP (1) JP2003525229A (et)
KR (1) KR20030009374A (et)
CN (1) CN1420763A (et)
AP (2) AP1485A (et)
AR (1) AR032614A1 (et)
AU (1) AU3589701A (et)
BG (1) BG107055A (et)
BR (1) BR0108958A (et)
CA (1) CA2400950A1 (et)
CZ (1) CZ20022883A3 (et)
DO (1) DOP2001000130A (et)
EA (1) EA200200914A1 (et)
EC (1) ECSP013952A (et)
EE (1) EE200200497A (et)
GT (1) GT200100033A (et)
HN (1) HN2001000038A (et)
HR (1) HRP20020715A2 (et)
HU (1) HUP0204417A3 (et)
IL (1) IL151553A0 (et)
IS (1) IS6532A (et)
MX (1) MXPA02008568A (et)
NO (1) NO20024108L (et)
NZ (1) NZ520927A (et)
OA (1) OA12381A (et)
PE (1) PE20011113A1 (et)
PL (1) PL365071A1 (et)
SK (1) SK12542002A3 (et)
WO (1) WO2001064183A1 (et)
YU (1) YU66202A (et)
ZA (1) ZA200206764B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
WO2017143438A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292518A (en) * 1988-06-28 1994-03-08 Hauser-Kuhrts Prolonged-release drug tablet formulations
EP0669129A2 (de) * 1994-02-28 1995-08-30 Bayer Ag Expandierbare Arzneiformen mit kontrollierter Wirkstoffabgabe
WO2000012198A1 (de) * 1998-08-28 2000-03-09 Koch, Berthold Spülluft-regler für eine trockenvorrichtung für druckluft

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
EE200100153A (et) * 1998-09-14 2002-06-17 Ranbaxy Laboratories Limited Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292518A (en) * 1988-06-28 1994-03-08 Hauser-Kuhrts Prolonged-release drug tablet formulations
EP0669129A2 (de) * 1994-02-28 1995-08-30 Bayer Ag Expandierbare Arzneiformen mit kontrollierter Wirkstoffabgabe
WO2000012198A1 (de) * 1998-08-28 2000-03-09 Koch, Berthold Spülluft-regler für eine trockenvorrichtung für druckluft

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
PL365071A1 (en) 2004-12-27
YU66202A (sh) 2005-09-19
KR20030009374A (ko) 2003-01-29
NO20024108L (no) 2002-10-25
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
CA2400950A1 (en) 2001-09-07
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
HUP0204417A3 (en) 2005-03-29
CZ20022883A3 (cs) 2003-04-16
CN1420763A (zh) 2003-05-28
IS6532A (is) 2002-08-28
AP2002002627A0 (en) 2002-09-30
BG107055A (bg) 2003-06-30
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
HN2001000038A (es) 2005-03-23
IL151553A0 (en) 2003-04-10
OA12381A (en) 2004-09-06
AR032614A1 (es) 2003-11-19
PE20011113A1 (es) 2001-10-14
NO20024108D0 (no) 2002-08-28
SK12542002A3 (sk) 2003-05-02
HRP20020715A2 (en) 2004-12-31
DOP2001000130A (es) 2004-03-31
NZ520927A (en) 2003-06-30
EA200200914A1 (ru) 2003-02-27
WO2001064183A1 (en) 2001-09-07
EE200200497A (et) 2004-02-16
AU3589701A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
MX339071B (es) Almidon pregelatinizado en una formulacion de liberacion controlada.
MY118371A (en) Tetrahydrolipstatin containing compositions
PL334656A1 (en) Dosage forms and methods of achieving betterement in cases of erection disorderamong male patients
IL143375A0 (en) Sustained release matrix systems for highly soluble drugs
BG105339A (en) Orally administered controlled drug delivery system providing temporal and spatial control
AU2001263228A1 (en) Rapidly disintegrating solid oral dosage form
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
MXPA04003807A (es) Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno.
IL150895A0 (en) Oral, nasal and pulmonary formulations of copolymer-1
NO306894B1 (no) Anvendelse av galanthamin for fremstilling av en farmasöytisk formulering for behandling av nikotinavhengighet
HK1087336A1 (en) Pharmaceutical composition comprising lumiracoxib
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
PL1608349T3 (pl) Układ do ustnego dostarczania zawierający środek przeciwbakteryjny i środek przeciwzapalny
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
MY129314A (en) Pharmaceutical composition comprising sumatriptan
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
GEP20043377B (en) Pharmaceutical Complex
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
UY26605A1 (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina
AU2001295839A1 (en) Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
MY145885A (en) Controlled release formulations for oral administration